Publications by authors named "A B Apolo"

Claim this Profile
F
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.
R J Motzer, B Escudier, M Burotto, T Powles, A B Apolo

Ann Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Rana R McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges, Andrea Apolo

CA Cancer J Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.
Andrea Necchi, Matthew D Galsky, Nazli Dizman, David H Aggen, Neeraj Agarwal, Andrea B Apolo

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications.
Rod Carlo A Columbres, Andrea B Apolo, A Rouf Banday

Bladder Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.
Viranda H Jayalath, Melissa Assel, Gopa Iyer, Scot Niglio, Bernard H Bochner, Andrea B Apolo

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis